Jiangsu Nanfang Medical Cash Flow Conversion Efficiency

Latest as of September 2025: 0.048x

Jiangsu Nanfang Medical cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has a cash flow conversion efficiency ratio of 0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.53 Million ≈ $1.83 Million USD) by net assets (CN¥259.57 Million ≈ $37.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Nanfang Medical (2012–2025)

Cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2025. This chart illustrates how Jiangsu Nanfang Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 603880 stock price for real-time trading data and today's change.

Jiangsu Nanfang Medical Cash Flow Conversion Ratio Explained

Jiangsu Nanfang Medical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Nanfang Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Nanfang Medical ranked by their cash flow conversion efficiency. Also see Jiangsu Nanfang Medical (603880) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
John Marshall Bancorp Inc NASDAQ:JMSB	0.018x
Orchestra BioMed Holdings Inc. NASDAQ:OBIO	-0.657x
Taiwan Paiho Ltd TW:9938	0.049x
Symtek Automation Asia Co Ltd TW:6438	0.039x
Aurora Cannabis Inc TO:ACB	-0.008x
ADTRAN Inc NASDAQ:ADTN	0.025x
Peijia Medical Limited F:4WO	-0.127x
eMudhra Limited NSE:EMUDHRA	0.013x

Annual Cash Flow Conversion Efficiency for Jiangsu Nanfang Medical (2012–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2025. Review Jiangsu Nanfang Medical free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥181.17 Million ≈ $26.51 Million	CN¥47.73 Million ≈ $6.98 Million	0.263x	+18.34%
2024-12-31	CN¥284.41 Million ≈ $41.62 Million	CN¥63.32 Million ≈ $9.27 Million	0.223x	+580.74%
2023-12-31	CN¥474.22 Million ≈ $69.39 Million	CN¥15.51 Million ≈ $2.27 Million	0.033x	-35.01%
2022-12-31	CN¥621.48 Million ≈ $90.94 Million	CN¥31.28 Million ≈ $4.58 Million	0.050x	+139.12%
2021-12-31	CN¥654.90 Million ≈ $95.83 Million	CN¥-84.25 Million ≈ $-12.33 Million	-0.129x	-158.50%
2020-12-31	CN¥700.80 Million ≈ $102.55 Million	CN¥154.12 Million ≈ $22.55 Million	0.220x	+278.28%
2019-12-31	CN¥567.52 Million ≈ $83.05 Million	CN¥32.99 Million ≈ $4.83 Million	0.058x	-38.28%
2018-12-31	CN¥560.04 Million ≈ $81.95 Million	CN¥52.75 Million ≈ $7.72 Million	0.094x	+2.84%
2017-12-31	CN¥537.57 Million ≈ $78.66 Million	CN¥49.24 Million ≈ $7.20 Million	0.092x	-76.34%
2016-12-31	CN¥256.69 Million ≈ $37.56 Million	CN¥99.35 Million ≈ $14.54 Million	0.387x	-5.01%
2015-12-31	CN¥222.51 Million ≈ $32.56 Million	CN¥90.66 Million ≈ $13.27 Million	0.407x	+16.89%
2014-12-31	CN¥210.90 Million ≈ $30.86 Million	CN¥73.52 Million ≈ $10.76 Million	0.349x	+191.73%
2013-12-31	CN¥168.57 Million ≈ $24.67 Million	CN¥20.14 Million ≈ $2.95 Million	0.119x	-80.93%
2012-12-31	CN¥121.38 Million ≈ $17.76 Million	CN¥76.07 Million ≈ $11.13 Million	0.627x	--

About Jiangsu Nanfang Medical

SHG:603880 China Medical Instruments & Supplies

Market Cap

$327.37 Million

CN¥2.24 Billion CNY

Market Cap Rank

#14101 Global

#4191 in China

Share Price

CN¥7.74

Change (1 day)

-3.85%

52-Week Range

CN¥5.74 - CN¥10.23

All Time High

CN¥16.80